Valeant’s Drug Price Strategy Enriches It, but Infuriates Patients and Lawmakers

A pharmaceutical company buys old drugs and increases the price multifold, a profitable business model that is drawing anger and making the traditional drug industry nervous.

via NYT > Your Money http://ift.tt/1FNV9dI

via WordPress http://ift.tt/1QSPP95